Immatics IMTX
NASDAQ IMTX
$7.54 -0.15 (-1.95%)
At close: Oct 22, 2026 · 4:00 PM EDT

Immatics (IMTX) Cash from Discontinued Operations (2019 - 2024)

Updated

Analysis

Immatics (IMTX) Cash from Discontinued Operations (2019 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Immatics 904.15 Mn -1.12 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -37.04 Mn
Jun 30, 2024 -35.77 Mn
Mar 31, 2024 -35.42 Mn
Sep 30, 2023 -33.23 Mn
Jun 30, 2023 -7.20 Mn
Mar 31, 2023 -25.45 Mn
Mar 31, 2022 122.45 Mn
Mar 31, 2021 -20.09 Mn
Sep 30, 2020 -56.24 Mn
Sep 30, 2019 52.66 Mn
API Access

Immatics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=IMTX&period=max&api_key=YOUR_API_KEY